Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines Journal Article


Authors: Somwar, R.; Erdjument-Bromage, H.; Larsson, E.; Shum, D.; Lockwood, W. W.; Yang, G.; Sander, C.; Ouerfelli, O.; Tempst, P. J.; Djaballah, H.; Varmus, H. E.
Article Title: Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines
Abstract: We previously described four small molecules that reduced the growth of lung adenocarcinoma cell lines with either epidermal growth factor receptor (EGFR) or KRAS mutations in a high-throughout chemical screen. By combining affinity proteomics and gene expression analysis, we now propose superoxide dismutase 1 (SOD1) as the most likely target of one of these small molecules, referred to as lung cancer screen 1 (LCS-1). siRNAs against SOD1 slowed the growth of LCS-1 sensitive cell lines; conversely, expression of a SOD1 cDNA increased proliferation of H358 cells and reduced sensitivity of these cells to LCS-1. In addition, SOD1 enzymatic activity was inhibited in vitro by LCS-1 and two closely related analogs. These results suggest that SOD1 is an LCS-1-binding protein that may act in concert with mutant proteins, such as EGFR and KRAS, to promote cell growth, providing a therapeutic target for compounds like LCS-1.
Keywords: unclassified drug; human cell; cancer growth; adenocarcinoma; cell proliferation; cell division; apoptosis; gene expression profiling; etoposide; lung neoplasms; epidermal growth factor receptor; small interfering rna; rna, small interfering; cancer cell culture; in vitro study; enzyme activity; cell line, tumor; cancer inhibition; lung adenocarcinoma; drug binding site; k ras protein; superoxide dismutase; complementary dna; molecularly targeted therapy; affinity chromatography; chemical biology; gene interaction network; target discovery and validation; 4,5 dichloro 2 meta tolylpyridazin 3(2h)one
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 108
Issue: 39
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2011-09-27
Start Page: 16375
End Page: 16380
Language: English
DOI: 10.1073/pnas.1113554108
PROVIDER: scopus
PMCID: PMC3182729
PUBMED: 21930909
DOI/URL:
Notes: --- - "Export Date: 2 November 2011" - "CODEN: PNASA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul J Tempst
    324 Tempst
  2. Romel Somwar
    111 Somwar
  3. Ouathek Ouerfelli
    102 Ouerfelli
  4. Guangli Yang
    34 Yang
  5. Hakim Djaballah
    101 Djaballah
  6. Erik Larsson
    11 Larsson
  7. Chris Sander
    210 Sander
  8. David Shum
    54 Shum
  9. Harold Varmus
    96 Varmus